Supplements
L-carnitine and male fertility
L-carnitine has been studied mainly for sperm motility. Pregnancy evidence remains limited.
- Published
- Modified
- Clinician review
- Not yet
Short answer
L-carnitine, often combined with acetyl-L-carnitine, has been studied in men with low sperm motility. Some trials report better motility. Evidence that the combination improves pregnancy or live birth is limited and uncertain. A motility change is not a fertility result.
Key takeaways
- Carnitine is involved in sperm energy metabolism. That is the biological rationale, not proof.
- Trials often run for about three to six months and use gram-level doses of L-carnitine, sometimes with acetyl-L-carnitine.
- Those doses are trial descriptions only.
- Do not combine several “motility stacks” and assume the trials still apply.
What it is
Carnitine helps shuttle fatty acids into mitochondria. Sperm use that machinery for movement, which is why motility trials exist. L-carnitine and acetyl-L-carnitine are related molecules and are not interchangeable on a label.
What studies show
Placebo-controlled studies in men with asthenozoospermia or broader semen abnormalities have reported increases in progressive or total motility. Concentration and morphology sometimes move and sometimes do not. Protocols have used L-carnitine around 2 grams a day, with or without about 1 gram of acetyl-L-carnitine, for several months. That is a description of what was studied. It is not SemenBoost’s suggested intake.
Pregnancy
A minority of carnitine trials report pregnancies. The numbers are small, the couples differ, and assisted reproduction is sometimes mixed in. Cochrane’s antioxidant review is the fairer summary of outcome certainty: very low for live birth across oral antioxidants, and sensitive to bias. Carnitine does not get a stronger outcome rating than that on this site.
Safety
Trial doses can cause stomach upset or a fishy body odour. People with seizure disorders, significant thyroid disease, or on dialysis should not add gram doses without medical advice. Carnitine is not a reason to delay investigation of very low motility.
Evidence
Limited evidenceMotility trials exist and are the reason carnitine is discussed. They do not justify a claim that carnitine restores fertility.
Semen parameters
Motility is the parameter with the most supportive, still limited, trial evidence. Other parameters are inconsistent.
Pregnancy and live birth
Pregnancy results are too sparse and too confounded to treat carnitine as a proven way to conceive.
A change in a semen measurement is not the same finding as a pregnancy or a live birth.
Related
Sources
- Antioxidants for male subfertility — Cochrane, 2022
- WHO laboratory manual for the examination and processing of human semen, 6th edition — World Health Organization, 2021
How this page was prepared
Drafted with automated research assistance and checked against the cited primary sources. A named clinician has not reviewed this page. Medical review is pending. Changes to reference values are not published automatically.